Skip to main content
. 2017 Nov 22;61(12):e01352-17. doi: 10.1128/AAC.01352-17

TABLE 2.

Comparison of quantitative measures of bias and precision for the PPRU study and prophylaxis study models

Model and data set PEc (μg/ml) MPEd (%) MAPEe (%)
PPRU study modela
    PPRU study 0.132 (−4.76, 8.39) 15.3 (−51.1, 153) 35.7
    Prophylaxis study 0.429 (−3.31, 11.2) 41.9 (−43.3, 302) 57.6
    Merged 0.338 (−6.10, 9.86) 33.7 (−64.4, 296) 59.2
Prophylaxis study modelb
    Prophylaxis study 0.339 (−3.61, 3.10) 12.2 (−47.4, 141) 31.8
    PPRU study 2.45 (−4.05, 65.4) 188 (−40.3, 848) 195
    Merged −0.245 (−5.15, 9.66) 20.1 (−66.4, 250) 53.9
a

Patients in the PPRU study received fluconazole at 3 to 12 mg/kg i.v., given every 1 to 3 days.

b

Patients in the prophylaxis study received fluconazole at 6 mg/kg twice weekly (Tuesdays and Fridays) i.v. or p.o.

c

PE, prediction error, which is presented as the median (2.5th percentile, 97.5th percentile).

d

MPE, mean prediction error, which is presented as the mean (2.5th percentile, 97.5th percentile).

e

MAPE, mean absolute prediction error.